0 year timescale. Such
glucose control can have beneÔ¨Åcial effects on microvascular complications in a shorter period of time. However,
when blood glucose lowering agents are used that have
the risk of severe hypoglycaemia, this can increase the
risk of cardiovascular events and death, as detailed in the
ADA and ESC-EASD guidelines.18,129 As many people with
a DFU and PAD also have atherosclerotic disease in other